NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 263 filers reported holding NEOGENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,637,361 | -21.5% | 1,759,135 | +2.6% | 0.01% | -14.3% |
| Q2 2023 | $27,559,327 | -14.9% | 1,714,955 | -7.8% | 0.01% | -22.2% |
| Q1 2023 | $32,390,226 | +491.6% | 1,860,438 | +214.0% | 0.01% | +350.0% |
| Q4 2022 | $5,474,709 | -51.7% | 592,501 | -55.0% | 0.00% | -50.0% |
| Q3 2022 | $11,333,000 | +3.8% | 1,316,293 | -1.8% | 0.00% | +33.3% |
| Q2 2022 | $10,921,000 | -32.3% | 1,340,048 | +1.0% | 0.00% | -25.0% |
| Q1 2022 | $16,121,000 | -87.4% | 1,326,849 | -64.6% | 0.00% | -87.1% |
| Q4 2021 | $127,905,000 | -33.8% | 3,748,623 | -6.5% | 0.03% | -36.7% |
| Q3 2021 | $193,345,000 | -4.8% | 4,007,964 | -10.8% | 0.05% | -2.0% |
| Q2 2021 | $202,993,000 | -12.8% | 4,493,951 | -6.8% | 0.05% | -19.4% |
| Q1 2021 | $232,659,000 | -19.9% | 4,823,965 | -10.5% | 0.06% | -26.2% |
| Q4 2020 | $290,283,000 | +52.8% | 5,391,567 | +4.7% | 0.08% | +31.2% |
| Q3 2020 | $189,930,000 | +40.2% | 5,148,531 | +17.7% | 0.06% | +33.3% |
| Q2 2020 | $135,494,000 | +27.1% | 4,373,636 | +13.3% | 0.05% | +6.7% |
| Q1 2020 | $106,624,000 | +58.8% | 3,861,808 | +68.2% | 0.04% | +114.3% |
| Q4 2019 | $67,154,000 | +143.1% | 2,295,873 | +58.9% | 0.02% | +200.0% |
| Q3 2019 | $27,624,000 | -15.6% | 1,444,813 | -3.2% | 0.01% | -12.5% |
| Q2 2019 | $32,733,000 | -2.5% | 1,491,885 | -9.0% | 0.01% | -27.3% |
| Q1 2019 | $33,556,000 | +3117.3% | 1,640,055 | +1882.3% | 0.01% | – |
| Q4 2018 | $1,043,000 | -23.1% | 82,736 | -6.4% | 0.00% | – |
| Q3 2018 | $1,357,000 | +41.5% | 88,388 | +20.8% | 0.00% | – |
| Q2 2018 | $959,000 | +72.5% | 73,169 | +7.4% | 0.00% | – |
| Q1 2018 | $556,000 | +82.3% | 68,148 | +97.9% | 0.00% | – |
| Q4 2017 | $305,000 | -19.9% | 34,439 | +0.6% | 0.00% | – |
| Q3 2017 | $381,000 | +30.0% | 34,229 | +4.7% | 0.00% | – |
| Q2 2017 | $293,000 | -71.2% | 32,692 | -73.6% | 0.00% | – |
| Q3 2016 | $1,018,000 | +15.0% | 123,819 | +12.5% | 0.00% | – |
| Q2 2016 | $885,000 | -11.0% | 110,021 | -25.4% | 0.00% | – |
| Q1 2016 | $994,000 | -56.3% | 147,457 | -49.0% | 0.00% | -100.0% |
| Q4 2015 | $2,277,000 | +37.0% | 289,389 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $1,662,000 | +534.4% | 290,110 | +499.2% | 0.00% | – |
| Q2 2015 | $262,000 | – | 48,418 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |